SINT Price / Book | Sintx Technologies, Inc.

Sintx Technologies, Inc. (SINT) Price / Book

2026-09-03: Price/Book Ratio 2.11.
2026-06-30: Price/Book Ratio 2.56.
2026-03-31: Price/Book Ratio 11.41.
2025-12-31: Price/Book Ratio 5.23.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-03-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	2.11
2026-06-30	2.56
2026-03-31	11.41
2025-12-31	5.23
2025-09-30	3.64
2025-06-30	2.01
2025-03-31	1.09
2024-12-31	1.21
2024-09-30	0.78
2024-06-30	0.41
2024-03-31	51.46
2023-12-31	0.23
2023-09-30	63.78
2023-06-30	74.95
2023-03-31	104.15
2022-12-31	184.01
2022-09-30	16,808.35
2022-06-30	17,765.27
2022-03-31	20,862.55
2021-12-31	184.52
2021-09-30	32,872.95
2021-06-30	44,158.61
2021-03-31	39,122.09
2020-12-31	29,876.98
2020-09-30	34,237.39
2020-06-30	38,465.03
2020-03-31	8,428.4
2019-12-31	13,943.38
2019-09-30	15,765.17
2019-06-30	14,689.41
2019-03-31	366,983.02
2018-12-31	9,341.25
2018-09-30	402,632.35
2018-06-30	376,491.61
2018-03-31	651,600.69
2017-12-31	1,091,705.9
2017-09-30	625,256,482.76
2017-06-30	8,067,140,072.78
2017-03-31	7,695,631,422.04
2016-12-31	920,687.69
2016-09-30	10,193,422.72
2016-06-30	12,966,290.73
2016-03-31	11,659,802.23
2015-12-31	9,762,075.03
2015-06-30	497,766,732.1
2015-03-31	346,690,706.46
2014-12-31	21,977,285.42
2014-09-30	187,283,185.77
2014-06-30	406,758,895.54
2014-03-31	490,596,476.62

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)	United States	$0.012B
Picard Medical, Inc. (PMI)	United States	$0.011B	-0.01
CERENOME, INC. (CNSY)	United States	$0.014B
ALLURION TECHNOLOGIES, INC. (ALUR)	United States	$0.010B
SeaStar Medical Holding Corp (ICU)	United States	$0.015B	-1.14
Modular Medical, Inc. (MODD)	United States	$0.018B	-0.88
Co-Diagnostics, Inc. (CODX)	United States	$0.007B	-0.32
enVVeno Medical Corp (NVNO)	United States	$0.006B	-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)	United States	$0.006B	-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)	United States	$0.005B